Business Description
Carasent AB (publ)
ISIN : SE0023261599
Total Employee Number:
196Description
Carasent AB (publ) Formerly Carasent AB is a comprehensive provider of cloudbased EHR solutions and platform services for various organizations within the healthcare sector. With Webdoc as the main product, the group offers a broad ecosystem of services, including solutions for patient communication and business intelligence. Geographically, the company operates in the Nordic region and Germany. It derives maximum revenue from Nordic Region. The solutions provides by the group are: Webdoc; Metodika; Medrave; HPI plustoo; Ad Curis; Ad Opus; Webcur; Data-AL; and Data-Cur.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.5 | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | 0.37 | |||||
Interest Coverage | 135.69 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 6.99 | |||||
Beneish M-Score | -2.51 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 23.8 | |||||
3-Year EBITDA Growth Rate | 14.5 | |||||
3-Year EPS without NRI Growth Rate | -17.9 | |||||
3-Year FCF Growth Rate | 79.2 | |||||
3-Year Book Growth Rate | -10.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 39.06 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 18.51 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.58 | |||||
Quick Ratio | 1.58 | |||||
Cash Ratio | 1.05 | |||||
Days Sales Outstanding | 44.32 | |||||
Days Payable | 72.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 4.9 | |||||
Shareholder Yield % | 3.04 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 84.09 | |||||
Operating Margin % | 3.69 | |||||
Net Margin % | 11.63 | |||||
EBITDA Margin % | 22.25 | |||||
FCF Margin % | 10.75 | |||||
OCF Margin % | 22.64 | |||||
ROE % | 4.86 | |||||
ROA % | 4.1 | |||||
ROIC % | 1.54 | |||||
3-Year ROIIC % | 14.66 | |||||
ROC (Joel Greenblatt) % | 37.16 | |||||
ROCE % | 1.47 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 39.48 | |||||
Forward PE Ratio | 3.13 | |||||
PE Ratio without NRI | 39.48 | |||||
Shiller PE Ratio | 23.4 | |||||
Price-to-Owner-Earnings | 31.89 | |||||
PS Ratio | 4.63 | |||||
PB Ratio | 1.96 | |||||
Price-to-Tangible-Book | 15 | |||||
Price-to-Free-Cash-Flow | 44.64 | |||||
Price-to-Operating-Cash-Flow | 20.78 | |||||
EV-to-EBIT | 110.92 | |||||
EV-to-EBITDA | 18.41 | |||||
EV-to-Revenue | 4.1 | |||||
EV-to-FCF | 38.36 | |||||
Price-to-GF-Value | 0.83 | |||||
Price-to-Projected-FCF | 5 | |||||
Price-to-Graham-Number | 5 | |||||
| Price-to-Net-Current-Asset-Value | 15 | |||||
Earnings Yield (Greenblatt) % | 0.9 | |||||
FCF Yield % | 2.44 | |||||
Forward Rate of Return (Yacktman) % | 16.75 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:APXZF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Carasent AB (publ) Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 37.22 | ||
| EPS (TTM) ($) | 0.062 | ||
| Beta | 1.6051 | ||
| 3-Year Sharpe Ratio | -59.39 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 0.15 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.15 - 0.15 | ||
| Shares Outstanding (Mil) | 66.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Carasent AB (publ) Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Carasent AB (publ) Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-15 | In 108 days | ||
| Third quarter earnings results for 2026 | 2026-10-15 | In 108 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-10 | In 11 days | ||
| Second quarter earnings results for 2026 | 2026-07-10 | In 11 days | ||
| General meeting for 2026 | 2026-04-20 10:00 | 0.15 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-04-14 08:00 | 0.15 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-04-14 07:00 | 0.15 (+0.00%) | ||
| Annual report for 2025 | 2026-03-19 | 0.15 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-12 08:00 | 0.15 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-12 07:00 | 0.15 (+0.00%) |
Show
Entries
Carasent AB (publ) Frequently Asked Questions
What is Carasent AB (publ)(APXZF)'s stock price today?
The current price of APXZF is $0.15. The 52 week high of APXZF is $0.15 and 52 week low is $0.15.
When is next earnings date of Carasent AB (publ)(APXZF)?
The next earnings date of Carasent AB (publ)(APXZF) is 2026-07-10.
Does Carasent AB (publ)(APXZF) pay dividends? If so, how much?
Carasent AB (publ)(APXZF) does not pay dividend.
Guru Commentaries on OTCPK:APXZF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Carasent AB (publ)
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers